Literature DB >> 32669986

BETA ENDORPHINS - HOLISTIC THERAPEUTIC APPROACH TO CANCER.

T G Shrihari1.   

Abstract

AIM: Endorphins are endogenous morphine, neuropeptides, produced in the pituitary gland in response to stress and pain. There are three types of endorphins beta-endorphins, enkephalins, and dynorphins binds to mu, kappa, and delta receptors situated on nervous system and immune cells. Cancer is a major threat to mankind killing millions of people around the world annually. There has been recent advancements in the field of surgery, chemotherapy, and radiotherapy, still the prognosis of cancer patients not improved much with increasing morbidity. We can't kill cancer cells without killing normal cells. Cancer cells and normal cells work alike. The aim of the review was to determine the anticancer activities of beta-endorphins.
MATERIALS AND METHODS: Articles regarding endorphins and its therapeutic application in cancer were searched on PubMed and Google scholar. This review includes studies, reviews, clinical trials and key findings of my research were included in the manuscript.
RESULTS: Beta-endorphin is an abundant endorphin, potent than morphine, synthesized and secreted in the anterior pituitary gland, it is a precursor of POMC (proopiomelanocortin). It has got various mechanisms of action such as analgesic activity, anti-inflammatory activity, immune stimulatory activity, stress buster activity, and euphoric activity.
CONCLUSION: Beta endorphin is an abundant endogenous morphine used for natural holistic preventive, therapeutic, promotive, and palliative treatment of cancer without adverse effects and inexpensive. © Association of Resident Doctors, UCH, Ibadan.

Entities:  

Keywords:  Cortisol; HPA-axis.; IL-1 β; IL-6; Meditation; NF-Kb; STAT-3; Stress; TNF-α

Year:  2019        PMID: 32669986      PMCID: PMC7358813     

Source DB:  PubMed          Journal:  Ann Ib Postgrad Med


INTRODUCTION

Cancer is a major cause of death worldwide[1]. Cancers are mainly due to external environmental factors such as tobacco in the chewable and non-chewable form, chemical ingestion, alcohol consumption, dietary factors and viruses such as HPV (Human Papilloma virus).[1] Chronic inflammation is considered as a seventh hallmark of cancer.[1,4] Cancer cells work like normal cells, "I do not know how to kill the cancer cells without killing normal cells said" by a Nobel laureate hungarian biochemist, Albert Szent-Gyorgyi.[1,29] Advanced treatment modalities such as surgery, radiotherapy, and chemotherapy fail to improve the cancer prognosis, which is around 50% with an increasing morbidity and mortality rate. The present concept of holistic healing rather than healing a part of the body yields better results without complications. Endorphins are endogenous morphine, more potent than morphine acts as neuropeptides produced by the pituitary gland through hypothalamus in response to psychological stress, pain, sex, intense physical exercise, yoga, meditation, acupuncture, quantum healing, music therapy.[14,16,20,21,22,25,26,29] It is also responsible for euphoria after vigorous exercise, creating a psychological relaxed state known as "runner's high".[2-7,15,16,29] Endorphins are mainly of three types, β-endorphins, enkephalins and dynorphins binds to mu, delta and kappa receptors respectively present on the immune cells and nervous system. β-endorphins are the abundant endorphins, more potent than morphine, synthesized and stored in the anterior pituitary gland, it is a precursor of proopiomelanocortin (POMC) which binds to the µ receptors and their ligands present on the immune cells and nervous system.[13,26] Neuroendocrinal pathway connects between nervous system, endocrinal system, and immune cells in human body. Neuroendocrinal system, which connects CNS (central nervous system) to PNS (peripheral nervous system) via HPA (Hypothalamo-pituitary axis) and ANS (Autonomic nervous system) through direct nerve fiber connections with cells or the organs of the immune cells. Chronic psychological stress is one of the predisposing factor for cancer along with depression, frustration, fear, hatred results in release of CRH (corticotrophic releasing hormone) from hypothalamus activates hypothalamo-pituitary adrenal axis (HPA-axis) through sympathetic nervous system activity of ANS release neurohormones such as cortisol, ACTH, and noradrenaline. These neurohormones induced inflammatory mediators such as IL-1 β, TNF-α, IL-6 and COX-2 inflammatory mediators activate key transcription factors NF-KB and STAT-3 promotes cell proliferation, angiogenesis, immunosuppressant, cell survival, invasion and metastasis leads to cancer.[2,3,6,7,10,11,17,19,21,22,23,29,31,32,33] Chronic inflammation is considered as a seventh hallmark of cancer. Disassociation of beta-catenin from E-cadherin is an indicator of epithelial to mesenchymal transition.[30] As the process of blocking the release of neurohormones such as cortisol, ACTH, and noradrenalin is due to opoid receptor mediated hyperpolarization of neuronal cells. Increased levels of free beta-Catenin are demonstrative of a loss of cell adhesion.[1,9,10,11,12,30].

DISCUSSION

Holistic approach of beta–endorphins in treatment of cancer:

Endorphins are natural morphine like substances, mainly β- endorphins, which is an abundant endorphins binds to µ receptors present on the immune cells such as macrophages, T and B lymphocytes, monocytes, and NK cells results in production of antiinflammatory cytokines such as IL-18, IL-10, IFN-γ. NK cells are the natural first line of defense against cancer and antiviral activity by producing IFN- γ, opsonin and granzyme-B.[14,17,18,19,20,25,29] β-endorphins produce analgesia by inhibiting substance P, a neurotransmitter of pain in the peripheral nervous system through presynaptic µ (mu)-receptor binding. β-endorphins produce euphoria, rewarding and analgesic effect by inhibiting GABA neurotransmitter and stimulating dopamine release after binding to µ receptors in the central nervous system.[21,22,23,26,27,34] Betaendorphin inhibit chronic psychological stress by binding of betaendorphin to the µ receptors situated on the central nervous system results in inhibition of GABA inhibitory neurotransmitter and produce dopamine neurotransmitter involved in analgesic activity, euphoria, and stress buster activity. Betaendorphin inhibit chronic psychological stress mediated inhibition of HPA-axis through autonomic nervous system (ANS) inhibits release of stress releasing neurohormones such as cortisol, ACTH, and noradrenalin. These neurohormones activate inflammatory mediators such as IL-1, TNF-α, IL-6, which further activate NF-KB and STAT-3 transcription factors involved in tumor progression. It is also involved in suppression of sympathetic neuronal function and the parasympathetic neuronal stimulation by beta-endorphin neurons results in activation of anti-inflammatory cytokines and peripheral immunity involved in inhibition of tumor growth and progression. Anti-inflammatory activity by suppressing proinflammatory cytokines such as IL- 1, IL-6, and TNF-α, free radicals release such as ROS and RNS by cytokines, immune cells, which is involved in tissue injury, cell aging, cell death, genetic mutation, and immunesuppression. Betaendorphins also activate anti-inflammatory cytokines such as IL-18, IL-10 and INF-g. [25,26,30,31] Beta-endorphins mediated reduced cortisol secretion results in increases innate immune cell activity such as NK cells and macrophages.[8,13,14,15,16,17,20,21,22,23,24,25,26] It also inhibits sympathetic neuronal excitatory activity and activates para sympathetic nervous system activity, improves peripheral immune activity by macrophages and NK cells. Immune cells such as T and B lymphocytes, monocytes, macrophages, produce betaendorphins. In inflammation recruitment of immune cells to the site of inflammation by chemokines produce endorphins especially beta-endorphins involved in anti-inflammatory activity by reducing inflammatory mediators such as TNF-α, IL-1, IL-6, IL-8, and inhibiting key transcription factor NF-KB induces cell proliferation, cellular apoptosis, angiogenesis, chronic inflammation, invasion and metastasis. Receptors of opoid peptides are increases in periphery during inflammation. (Anti-inflammatory and analgesic effect of betaendorphin by inhibiting the release of substance P, a neurotransmitter of pain and inflammation and noradrenaline at the peripheral nervous system, which activate inflammatory mediators such as IL-1, TNF-α, IL-6). Decrease in psychological stress level by inhibiting HPA-axis through sympathetic neuronal activity and activating parasympathetic neuronal activity, decreases cortisol and nor-adrenaline secretion, improves activity of innate immune cells such as NK cells, macrophages, produce interferon-gamma, opsonin, and granzyme-b involved in anti-tumor and anti-viral activity.[30,32,33] Beta-endorphins involved in alteration of environment of genes and gene expression in tumor microenvironment. It also prolong human life span by lengthening telomeres, which shortens with aging and anti-inflammatory activity by neutralizing free radicals such as ROS, RNS responsible for cell aging during oxidative stress. Beta-endorphins suppress the release of ROS, RNS, free radicals and NO (nitric oxide) from inflammatory cells and cytokines such as TNF-α, IL- 8, and tumor associated macrophages, tumor associated neutrophils, dendritic cells, involved in genetic mutation of tumor-suppressor gene p53, which is altered in more than 50% of all cancers, immune suppression, cell injury and cell death. Alteration of tumor micro-environment by suppressing catecholamine’s induced inflammatory cytokines (IL-1, TNF-α, IL-6) and increase in anti-inflammatory cytokines such as IL-10, IL-18. IFN-Gamma). Beta–endorphins suppress tumor progression by suppressing the release of catecholamine’s such as nor-adrenaline and cortisol mediated suppression of inflammatory mediators such as TNF-α, IL-1, COX-2, IL-6, involved in tumor progression by activating key transcription factors NFKB, STAT-3, in tumor micro-environment, which involved in cell proliferation, cell survival, angiogenesis, genomic instability, immune suppression, invasion and metastasis. Beta-endorphin helps in e-cadherin expression and inhibiting the activity of proteolytic enzymes matrix-metalloproteases -2,9 (mmp-2,9), upA (urokinase plasminogen activator) involved in extracellular matrix degradation, invasion and metastasis results in cell adhesion, prevents invasion and metastasis.[30] Endorphins especially b endorphins acts as a natural preventive, therapeutic and palliative holistic therapeutic approach to cancer without any adverse reactions.[24,28] Many in-vivo and in-vitro studies have shown that β- endorphins have antitumor activities at an early and later stages of cancer on animal and human cancer cells.[8-10,29] Tenderness, love, care for the patient. Practice of sympathy, empathy, compassion for caring patient produce endorphins is the ultimate treatment of choice.

Comments:

Thorough understanding of mechanism of action of beta-endorphin, duration of action, dose dependent action, prognosis related to stages of cancer will be useful for future therapeutic approach to cancer.

CONCLUSION AND FUTURE PERSPECTIVE

Endorphins are endogenous opioids, Beta-endorphins secreted by anterior pituitary gland in response to certain stress and painful conditions of our body. It has a natural stress buster, analgesic, euphoric and immune-stimulatory activity to combat against cancer without any adverse effects. Quantity of secretion of beta-endorphins, dose dependent effects of beta-endorphins on cancer-related to prognosis; need to be known for future preventive, promotive, therapeutic and palliative holistic treatment of cancer.
  25 in total

Review 1.  The effects of mind-body therapies on the immune system: meta-analysis.

Authors:  Nani Morgan; Michael R Irwin; Mei Chung; Chenchen Wang
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

Review 2.  Role of nervous system in cancer aetiopathogenesis.

Authors:  Katarina Ondicova; Boris Mravec
Journal:  Lancet Oncol       Date:  2010-06       Impact factor: 41.316

3.  Beta-endorphin cell therapy for cancer prevention.

Authors:  Changqing Zhang; Sengottuvelan Murugan; Nadka Boyadjieva; Shaima Jabbar; Pallavi Shrivastava; Dipak K Sarkar
Journal:  Cancer Prev Res (Phila)       Date:  2014-11-17

4.  Stress-induced modulation of NF-κB activation, inflammation-associated gene expression, and cytokine levels in blood of healthy men.

Authors:  Ulrike Kuebler; Claudia Zuccarella-Hackl; Angela Arpagaus; Jutta M Wolf; Firouzeh Farahmand; Roland von Känel; Ulrike Ehlert; Petra H Wirtz
Journal:  Brain Behav Immun       Date:  2014-12-31       Impact factor: 7.217

Review 5.  Impact of stress on cancer metastasis.

Authors:  Myrthala Moreno-Smith; Susan K Lutgendorf; Anil K Sood
Journal:  Future Oncol       Date:  2010-12       Impact factor: 3.404

6.  Effects of psychological stress on innate immunity and metabolism in humans: a systematic analysis.

Authors:  Sushri Priyadarshini; Palok Aich
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

7.  Acupuncture May Stimulate Anticancer Immunity via Activation of Natural Killer Cells.

Authors:  Michael Francis Johnston; Elizabeth Ortiz Sánchez; Nikola L Vujanovic; Wenhui Li
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-10       Impact factor: 2.629

8.  Modulation of immune responses in stress by Yoga.

Authors:  Sarika Arora; Jayashree Bhattacharjee
Journal:  Int J Yoga       Date:  2008-07

Review 9.  Dual role of inflammatory mediators in cancer.

Authors:  T G Shrihari
Journal:  Ecancermedicalscience       Date:  2017-02-23

10.  Levels of immune cells in transcendental meditation practitioners.

Authors:  Jose R Infante; Fernando Peran; Juan I Rayo; Justo Serrano; Maria L Domínguez; Lucia Garcia; Carmen Duran; Ana Roldan
Journal:  Int J Yoga       Date:  2014-07
View more
  1 in total

1.  Evaluation of the Influence of Biological Factors during the Course of Treatment in Patients with Ovarian Cancer.

Authors:  Daria Schneider-Matyka; Edyta Skwirczyńska; Maria Gaur; Beata Hukowska-Szematowicz; Sebastian Kwiatkowski; Marzena Mikla; Elżbieta Grochans; Aneta Cymbaluk-Płoska
Journal:  Int J Environ Res Public Health       Date:  2022-08-24       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.